ESTRO 2024 - Abstract Book

S4791

Physics - Quality assurance and auditing

ESTRO 2024

Conclusion:

The analyses did not show a general time-dependent trend in NTCP, NTI, or mean dose to selected OARs for any treatment type in the three time intervals. The results suggest that plan quality remained constant for both photon and proton plans. A consistent treatment plan quality ensures a robust patient selection for the clinical trials. It enables transparency in the trial outcome analysis and ensures the reliability of trial results. The ongoing monitoring of plan quality is set in place to ensure consistency.

Keywords: plan quality, NTCP, proton therapy

References:

1. Jensen K, Friborg J, Hansen CR, et al. The Danish Head and Neck Cancer Group (DAHANCA) 2020 radiotherapy guidelines. Radiother Oncol. 2020 Oct;151:149-151.